Dr.Harsha Doddihal

Echoes and Borrowed Wisdom , Clinical researcher, Second Opinion Oncologist, Board Member-Prana Healthcare Enablers.

[Dr Vineet Govinda Gupta @drvineetgovinda]

All of us should live life fully understanding and digesting and 100% internalising the truth that there is a non-zero probability that we won't see tomorrow. We could die of a heart attack, get hit by a car, have a stroke in our sleep, it's a non-zero probability that today is your last day.

In oncology lingo, I like to put it a different way: live like you're a patient with ALK+ metastatic lung cancer with your disease in remission on lorlatinib. You might live longer than your doctor (10+ year survivors are expected nowadays) or you might die tomorrow.

Death is the final truth of life, it seems silly that most of us live life ignoring something that is 100% guaranteed to happen to all of us. If you accept your mortality as an inevitability, you will live a life with less regrets. When you know there is a non-zero chance of dying today, you will be less likely to live a life that is not true to yourself.

Live life with no regrets.

[Stephen V Liu, MD @StephenVLiu]

This is a major story from #ASCO25. Randomized phase 3 trial of time of day of immunotherapy infusion. Randomized to infusion before or after 3pm. Early infusion far superior: PFS 11.3 vs 5.7 HR 0.42, OS HR 0.45! Impactful, pragmatic, not costly. This should be a bigger story.

[Vivek Subbiah, MD @VivekSubbiah]

⭐️Structured Exercise after Adjuvant Chemotherapy for Colon Cancer | New England Journal of Medicine @NEJM https://t.co/8DKYpJZSRE

[Vania Wisdom @WisdomVania]

Amazing to see how such a simple structured exercise intervention can be a game changer in the management of colon cancer disease! Innovation doesn’t need to be expensive or fancy! Congratulations to #ChrisBooth and all involved in the #CHALLENGE study. #ASCO2025 @ASCO

[Dr.Harsha Doddihal @Harshadod]

Etymology & History Learning https://t.co/KVQSt4kTym

[Dr.Harsha Doddihal @Harshadod]

Prediction of checkpoint inhibitor immunotherapy efficacy https://t.co/g8MsvwGo1f

[Dr.Harsha Doddihal @Harshadod]

Insights from Eli Lilly’s CEO: Innovation, Culture, and the Future of Healthcare https://t.co/spInqQvutm

[Dr.Harsha Doddihal @Harshadod]

Diversity, Fast Learning & the Challenge of French Class https://t.co/RRMk2XKh5G

[Dr.Harsha Doddihal @Harshadod]

People-Centred Care in Oncology https://t.co/Agpl7dwPL3

[Dr.Harsha Doddihal @Harshadod]

Conversation With ChatGPT https://t.co/Kg4gqOOTCm

[Dr.Harsha Doddihal @Harshadod]

Epigenetic Editing or Epi Editing https://t.co/df6WLZqtlY

[Dr.Harsha Doddihal @Harshadod]

China’s Leapfrog in New Drug Development https://t.co/11C8xmBAtQ

#Biotech #Innovation #DrugDevelopment #China #GlobalHealth

[Dr.Harsha Doddihal @Harshadod]

I just published India Emerges as Global Pharma’s Capability Centre Hub: A Look at the Driving Forces and Challenges https://t.co/sI4krOym3y

[Dr.Harsha Doddihal @Harshadod]

I just published My Experience With Gamified Learning https://t.co/wvLkxFXEhN

[Dr.Harsha Doddihal @Harshadod]

Emotional Distress and Its Impact on Immunotherapy Efficacy https://t.co/Q9UbZow9Vl

[Dr.Harsha Doddihal @Harshadod]

Leman Biotech _EPFL_China
#Meta10-19, #CART Therapy, #Cancer #DLBCL #ALL
100% Complete Response Phase 1 Study.

https://t.co/wiAdEc5XdE

[Dr.Harsha Doddihal @Harshadod]

“Learnings of the Bhagavad Gita with Business Relevance:” by Harsha Doddihal

Gita Jayanti https://t.co/Iytk5XeumR

[Dr.Harsha Doddihal @Harshadod]

Common Sense Oncology https://t.co/PR57IOHpiM

[Dr.Harsha Doddihal @Harshadod]

Forgive, O Lord, my little joke on thee,

And I’ll forgive thy great big one on me.

Robert Frost

[Dr.Harsha Doddihal @Harshadod]

I just published Key Learnings from Women Founders In Switzerland https://t.co/OKydTM3Fqp